Profile
Thomas Langenickel is Chief Medical & Development Officer at Gubra A since 2026.
Formerly, Dr. Langenickel was Chief Medical Officer at ETHRIS GmbH.
Dr. Langenickel earned a doctorate from Humboldt-Universität zu Berlin.
Thomas Langenickel active positions
| Companies | Position | Start |
|---|---|---|
| GUBRA A/S | Chief Tech/Sci/R&D Officer | 05/01/2026 |
Former positions of Thomas Langenickel
| Companies | Position | End |
|---|---|---|
ETHRIS GmbH
ETHRIS GmbH BiotechnologyHealth Technology Develop therapeutics for the treatment of asthma and rare pulmonary diseases | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Langenickel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Humboldt-Universität zu Berlin
Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
ETHRIS GmbH
ETHRIS GmbH BiotechnologyHealth Technology Develop therapeutics for the treatment of asthma and rare pulmonary diseases | Health Technology |
- Stock Market
- Insiders
- Thomas Langenickel
















